Litigation Details for Janssen Products, L.P. v. Lupin Limited (Fed. Cir. 2014)

Janssen Products, L.P. v. Lupin Limited (Fed. Cir. 2014)

Docket		Date Filed	2014-09-19
Court	Court of Appeals for the Federal Circuit	Date Terminated
Cause		Assigned To
Jury Demand		Referred To
Patents	6,248,775; 7,470,506; 7,700,645
Link to Docket	External link to docket

Details for Janssen Products, L.P. v. Lupin Limited (Fed. Cir. 2014)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2015-01-22	34		5,843,946 (“the ‘946 patent”); 6,248,775 (“the ‘775 patent”); RE 6 “Janssen” as set forth herein refers to… disclosed. U.S. PATENT DOCUMENTS 6,248,775 Bl 612001 Vazquez et al. …5,843,946; 6,248,775; RE 42,889; and RE 43,596. (See Raghavan Aff. ¶ 3). Those disputes have been fully and …pharmaceutical formulations in improved stability and 6,248,775, and in Bioorganic and Chemistry Letters, Vol.…hydroxypropylcarbamate as well as intermediates for use in 6,248,775 Bl 6/2001 Vazquez et al.	External link to document
2015-05-01	42		(A2536-52) Searle ‘775 U.S. Patent No. 6,248,775 B1 (A1632-746) …015 patent U.S. Patent No. 7,126,015 B2 (A371-95) ‘645 patent U.S. Patent No. … Janssen asserts ‘015 patent claim 1 and ‘645 patent claim 4. ‘015 patent claim 1 encompasses a… 645 Patent U.S Patent No 7126015 B2 the 015 Patent …Janssen asserted Lupin infringed ‘645 patent claim 4 and ‘015 patent claim 1; Lupin counterclaimed. 28	External link to document